Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Jupiter › NPI 1841408283
Lab

Access Medical Laboratories, INC.

Access Medical Laboratories, INC. was paid $1.06M by Medicaid between Jul 2021 and Aug 2022, across 3 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 92% of everything it billed.

33Billing provider infoACCESS MEDICAL LABORATORIES, INC.
JUPITER, FL 33458
33aNPI1841408283assigned 05/18/2007
28Total paid$1.06M
24GClaims30,497
24DCodes billed3
24AFirst – last monthJul 2021 – Aug 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#40 of 225
Median peer was paid$74K
This provider vs. median14×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Single-Code Concentration92% of spending on code U0003 with only 3 total codes billed. Highly concentrated billing profile.
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202116,318$579K
202214,179$483K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 92% 16,186 14,030 $972K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 6.0% 13,485 11,632 $64K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.5% 826 777 $26K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRAMIREZ, OSCAR (CFO)